A Newly Identified CG301269 Improves Lipid and Glucose Metabolism Without Body Weight Gain Through Activation of Peroxisome Proliferator–Activated Receptor α and γ

OBJECTIVE: Peroxisome proliferator–activated receptor (PPAR)-α/γ dual agonists have been developed to alleviate metabolic disorders. However, several PPARα/γ dual agonists are accompanied with unwanted side effects, including body weight gain, edema, and tissue failure. This study investigated the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Hyun Woo, Lee, Joo-Won, Kim, Woo Sik, Choe, Sung Sik, Kim, Kyung-Hee, Park, Ho Seon, Shin, Hyun Jung, Lee, Gha Young, Shin, Dongkyu, Lee, Hanjae, Lee, Jun Hee, Choi, Eun Bok, Lee, Hyeon Kyu, Chung, Heekyoung, Park, Seung Bum, Park, Kyong Soo, Kim, Hyo-Soo, Ro, Seonggu, Kim, Jae Bum
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Obesity Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028349/
https://www.ncbi.nlm.nih.gov/pubmed/21270261
http://dx.doi.org/10.2337/db09-1145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028349/
https://www.ncbi.nlm.nih.gov/pubmed/21270261
http://dx.doi.org/10.2337/db09-1145

Ejemplares similares